Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014

mCRPC: Challenges and opportunities in a booming area

Dr Nicolas Mottet - University Hospital, Saint-Étienne, France
mCRPC: Challenges and opportunities in a booming area ( Dr Nicolas Mottet - University Hospital, Saint-Étienne, France )
10 Jan 2014

Oncotype DX: changing breast cancer treatment

Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA
Oncotype DX: changing breast cancer treatment ( Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA )
19 Dec 2013

Meeting the needs of the elderly, unfit CLL patient

Prof Peter Hillmen - The Leeds Teaching Hospitals NHS Trust, Leeds, UK
Meeting the needs of the elderly, unfit CLL patient ( Prof Peter Hillmen - The Leeds Teaching Hospitals NHS Trust, Leeds, UK )
19 Dec 2013

Improving outcomes in chronic lymphocytic leukaemia

Prof John Gribben - Queen Mary University of London, UK and Prof Barbara Eichhorst - University of Cologne, Germany
Improving outcomes in chronic lymphocytic leukaemia ( Prof John Gribben - Queen Mary University of London, UK and Prof Barbara Eichhorst - University of Cologne, Germany )
19 Dec 2013

Translational studies of CDK and PARP inhibitors

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013

HER2 positive breast cancer treatment, past and future

Dr Edith Perez - Mayo Clinic, Rochester, USA
HER2 positive breast cancer treatment, past and future ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
19 Dec 2013

Where next for chronic lymphocytic leukaemia in the elderly?

Prof Clemens Wendter, Prof Florence Cymbalista, Prof Anders Österborg
Where next for chronic lymphocytic leukaemia in the elderly? ( Prof Clemens Wendter, Prof Florence Cymbalista, Prof Anders Österborg )
19 Dec 2013

Where to next for the elderly with acute myeloid leukaemia?

Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands
Where to next for the elderly with acute myeloid leukaemia? ( Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands )
19 Dec 2013

Exciting new developments in the treatment of multicentric Castleman disease

Prof Nikhil Munshi - Harvard Medical School, Massachussets, USA and Dr Raymond Wong - The Chinese University of Hong Kong
Exciting new developments in the treatment of multicentric Castleman disease ( Prof Nikhil Munshi - Harvard Medical School, Massachussets, USA and Dr Raymond Wong - The Chinese University of Hong Kong )
19 Dec 2013

New therapy aspects for myeloid chronic lymphoma

Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine
New therapy aspects for myeloid chronic lymphoma ( Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine )
19 Dec 2013